YZYBIO-B(02496): Shi Jian has been elected as a workers' representative supervisor.
Youzhiyou Biology-B (02496) announced that Dr. Wang Tao has resigned from the position of employee representative supervisor of the company due to personal career development reasons, effective from December 31, 2025. Dr. Shi Jian, Director of the Translational Medicine Department of the company, was democratically elected as the employee representative supervisor of the second supervisory board on December 31, 2025. Dr. Shi's term will be effective from December 31, 2025, and will expire at the end of the second supervisory board meeting.
YZYBIO-B(02496) Announcement: Dr. Wang Tao has resigned from his position as the employee representative supervisor of the company for personal career development reasons, effective from December 31, 2025. Dr. Shi Jian, Director of the Translational Medicine Department of the company, was democratically elected as the employee representative supervisor for the 2nd Supervisory Board, effective from December 31, 2025. Dr. Shi's term will end when the 2nd Supervisory Board concludes.
Related Articles

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


